Meeting
2017 Gastrointestinal Cancers Symposium
Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Authors
Kristien M. Jipping
University of Groningen, University Medical Center Groningen, Department of Surgical Oncology, Groningen, Netherlands
Kristien M. Jipping , Jan-Binne Hulshoff , Evita A. van Amerongen , Tim I. Bright , David I. Watson , John Theodorus Plukker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 113)
DOI
10.1200/JCO.2017.35.4_suppl.113
Abstract #
113
Poster Bd #
J5
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Induction chemoradiotherapy for esophageal cancer: Comparing CROSS regimen with cisplatin/5-FU.
First Author: Abraham Geller
Poster
2012 Gastrointestinal Cancers Symposium
Retrospective analysis of neoadjuvant chemoradiotherapy for esophageal cancer: The Knight Cancer Institute experience.
First Author: Faisal A Siddiqui
Poster
2019 Gastrointestinal Cancers Symposium
The association of 5FU-based chemotherapy with pathological response or survival compared to carbo/taxol with locally advanced resectable esophageal cancer.
First Author: Mohammed Al-Jumayli
Poster
2017 Gastrointestinal Cancers Symposium
Association between markers of malnutrition (MN) and toxicity (T) during neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer (EC).
First Author: Rishi Jain